• Anne: Physician, and on board the Ocean Viking

    All that mattered was survival when their path crossed that of the rescue ship Ocean Viking. As soon as they were hoisted onto the deck, the wounded survivors were taken care of by the medical team.

  • HIV: How does prevention reach people on the ground?

    How successful prevention interventions are depends on the acceptance of the population. Trust needs to be built to ensure that interventions reach where they are needed.

  • Antiretroviral therapy: Time to change the paradigm?

    Many patients with HIV infection receive triple therapy. However, according to a session at IAS 2021, modern regimens with two active agents are not inferior to this strategy.

  • Turning points and opportunities in HIV through COVID-19?

    In preparation for the 11th IAS conference in Berlin, the Tagesspiegel Expert Forum on Health focused on findings from the COVID-19 pandemic to help end AIDS by 2030 and improve care for people with HIV.

  • Curing HIV infections: Research news

    Guideline-compliant HIV therapies reduce the viral load, but do not lead to eradication. But the idea of curing HIV is not off the table. An overview of important approaches from basic research.

  • Urology and the environment: Where´s the overlap?

    The latest issue of "European Urology" dealt with climate change and our share of responsibility. The pandemic showed that virtual medical events improve the CO2 balance.

  • Structure of the HCN4 pacemaker channel resolved

    A recent study describes the atomic-level working mechanism of the HCN4 channel, the 'pacemaker' protein that regulates the heart's rhythmic activity.

  • Dr. Sarfati and robotic surgery, the future of breast reconstruction

    Robotic surgery can reduce scar sizes from brest reconstructon. The technique is on the rise, and in this interview, Dr. Sarfati explains his pioneering work with the Da Vinci Xi robot for this approach.

  • Ronaldo, Coca-Cola and PubMed

    The recent "controversy" involving Cristiano Ronaldo and Coca-Cola, one of the sponsors of the European football championship, sets the backdrop to explore the relationship between scientific research and private funding.

  • Post-COVID and neurological diseases: More frequently "hand in hand"

    Neurological diseases have been a growing global problem before COVID-19 pandemic. Now they are further pushed by the consequences of post-COVID or long-COVID infections.

  • When AI in healthcare becomes autonomous, who is responsible?

    AIs in healthcare are constantly being deployed in new fields. The question is now: Will AIs end up replacing the physician?

  • The ERC Guidelines 2021: Paediatric Life Support (7/7)

    Many underlying aetiologies and pathophysiological processes in paediatric critical illness differ from those in adults. The ERC 2021 Guidelines, devote an entire chapter to the topic.

  • The ASCO 2021 Podcast

    This podcast surveys state-of-the-art presentations on clinical oncology findings on mCRPC, metastatic oesophageal squamous cell cancer, primary breast cancer, and more.

  • The EULAR 2021 Podcast

    This EULAR 2021 correspondent's podcast revisits six congress state-of-the-art presentations on rheumatology topics, and research findings where the discipline overlapped with pediatrics, gastroenterology, and virology.

  • "Sudden cardiac death" in focus of ESC 2021

    On 27 August 2021, it's that time again: The European Society of Cardiology (ESC) will come together online for its annual congress. A brief programme overview.

  • Intensive care: (re)open to family members

    An Italian team has published a paper on the benefits of allowing ICU visits during a pandemic period, proposing essential policy and operational options for implementation.

  • A forum to denounce the instrumentalisation of history

    COVID waves are finally calming down but conspiracy theorists have begun to insult history itself.

  • The ERC Guidelines 2021: Post-resuscitation care (Part 6/7)

    The ERC 2021 guidelines on post-resuscitation care contain major updates to the 2015 version on coronary angiography, blood pressure target, seizure treatment, temperature control, and other topics.

  • Medical studies and empathy towards precarious patients

    However well-intentioned physicians may be, they are often torn between incomprehension and a certain helplessness when dealing with precarious patients.

  • Novel drug combination for recurrent ovarian cancer

    Mirvetuximab soravtansine, a folate receptor-targeting antibody-drug conjugate, in combination with bevacizumab, demonstrated impressive anti-cancer activity in the phase 1b FORWARD II trial.

  • 3 |
  • 4 |
  • 5 |
  • 6 |
  • 7 |
  • 8 |
  • 9 |
  • 10 |
  • 11 |
  • 12 |
  • 13 |